MedPath

Zyrexal

Zyrexal

Approved
Approval ID

27f61816-57bb-4638-a575-bf8be1562aed

Product Type

HUMAN PRESCRIPTION DRUG LABEL

Effective Date

Feb 10, 2020

Manufacturers
FDA

Vivera Pharmaceuticals, Inc.

DUNS: 081244342

Products 1

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

VIATMIN C, THIAMINE, VITAMIN B6, FOLATE,VITAMIN B12, VITAMIN B3, D-RIBOSE, COENZYME Q-10

Product Details

FDA regulatory identification and product classification information

FDA Identifiers
NDC Product Code72380-915
Product Classification
G
Generic Name
VIATMIN C, THIAMINE, VITAMIN B6, FOLATE,VITAMIN B12, VITAMIN B3, D-RIBOSE, COENZYME Q-10
Product Specifications
Route of AdministrationORAL
Effective DateFebruary 10, 2020
FDA Product Classification

INGREDIENTS (11)

FOLIC ACIDActive
Quantity: 1 mg in 1 1
Code: 935E97BOY8
Classification: ACTIB
ASCORBIC ACIDActive
Quantity: 125 mg in 1 1
Code: PQ6CK8PD0R
Classification: ACTIB
THIAMINE HYDROCHLORIDEActive
Quantity: 25 mg in 1 1
Code: M572600E5P
Classification: ACTIB
METHYLCOBALAMINActive
Quantity: 1 mg in 1 1
Code: BR1SN1JS2W
Classification: ACTIB
NIACINAMIDEActive
Quantity: 60 mg in 1 1
Code: 25X51I8RD4
Classification: ACTIB
PYRIDOXINEActive
Quantity: 12.5 mg in 1 1
Code: KV2JZ1BI6Z
Classification: ACTIB
.BETA.-D-RIBOSEActive
Quantity: 50 mg in 1 1
Code: IVV837V11N
Classification: ACTIB
UBIDECARENONEActive
Quantity: 75 mg in 1 1
Code: EJ27X76M46
Classification: ACTIB
MICROCRYSTALLINE CELLULOSEInactive
Code: OP1R32D61U
Classification: IACT
MAGNESIUM STEARATEInactive
Code: 70097M6I30
Classification: IACT
SILICON DIOXIDEInactive
Code: ETJ7Z6XBU4
Classification: IACT

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

Zyrexal - FDA Drug Approval Details